1. Home
  2. DRCT vs BRTX Comparison

DRCT vs BRTX Comparison

Compare DRCT & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Direct Digital Holdings Inc.

DRCT

Direct Digital Holdings Inc.

HOLD

Current Price

$0.06

Market Cap

8.9M

Sector

Technology

ML Signal

HOLD

Logo BioRestorative Therapies Inc. (NV)

BRTX

BioRestorative Therapies Inc. (NV)

HOLD

Current Price

$1.19

Market Cap

9.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DRCT
BRTX
Founded
2018
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Managed Health Care
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.9M
9.7M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
DRCT
BRTX
Price
$0.06
$1.19
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
25.1M
33.6K
Earning Date
11-06-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$35,369,000.00
$383,400.00
Revenue This Year
N/A
$112.14
Revenue Next Year
$25.40
$139.81
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1.70
52 Week Low
$0.05
$0.98
52 Week High
$2.61
$2.55

Technical Indicators

Market Signals
Indicator
DRCT
BRTX
Relative Strength Index (RSI) 28.98 53.48
Support Level $0.05 $1.00
Resistance Level $0.08 $1.21
Average True Range (ATR) 0.01 0.09
MACD 0.01 0.02
Stochastic Oscillator 21.09 69.92

Price Performance

Historical Comparison
DRCT
BRTX

About DRCT Direct Digital Holdings Inc.

Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

Share on Social Networks: